Hims stock soared 12% today and was trading at $56.00 at press time.
Trading volume was way up, and the stock’s been on a tear all week. Investors seem fired up about where the company’s headed in 2025, and this move just adds to its recent momentum.
Hims & Hers started the day at $50.00 and surged as high as $57.31 during intraday trading before easing back to close at $56.00, a sign of just how excited investors are about the company’s momentum and earnings outlook.
With its market cap now topping $12.2 billion, Hims ranked among the NYSE’s standout performers today.
Hims & Hers connects people with doctors online and offers everything from prescriptions to everyday wellness products, all through a straightforward, digital platform.
Hims stock: What’s fuelling today’s surge?
Hims & Hers is showing solid fundamentals, with analysts expecting a massive 177.8% jump in earnings per share next year, according to Zacks estimates.
That kind of growth outlook has kept investors interested and even after the recent run-up in price, the stock still looks reasonably valued.
Its forward price-to-sales ratio is actually sitting below the industry average, which could mean there’s more room to run.
The company’s clearly in expansion mode too. The recent acquisition of ZAVA and its move into the Canadian market suggest HIMS isn’t slowing down anytime soon.
As for insider activity, Michael Y. Chi is planning to sell a small chunk of shares, but it doesn’t look like a red flag as the sale is minor and isn’t expected to impact the float in any meaningful way.
What analysts say?
Hims stock might be riding high on price momentum and investor buzz, but analysts are taking a more measured view.
Most major analyst platforms, with coverage from 11 to 17 firms, generally rate the stock as a “Hold.”
Breaking it down: around 29% call it a “Strong Buy,” 6% say “Buy,” nearly half (47%) suggest “Hold,” while 12% rate it a “Sell” and 6% say “Strong Sell.”
The average 12-month price target falls somewhere between $40.73 and $41.78, well below current levels, hinting at limited upside or even a possible pullback.
That said, projections vary quite a bit, with some as bullish as $68 and others as low as $26.
The more cautious voices point to Hims’s high P/E ratio and recent volatility, warning that the stock could cool off after its sharp run-up.
That said, a few analysts are still pretty optimistic. They point to Hims’s solid earnings growth, strong cash flow, and better margins as reasons to stay bullish.
But even with that optimism, firms like Truist and Morgan Stanley have kept their price targets close to the current level, a sign that, overall, the Street’s taking a wait-and-see approach for now.
The post Hims stock soars 12% on earning hype but analysts still urge caution: here’s why appeared first on Invezz
